dos and don'ts while taking semaglutide GLP-1 drugs such as tirzepatide are transforming obesity and diabetes care in India, but experts warn that improper use could lead to significant muscle loss. A new India-specific consensus highlights The infographic compares 10 commonly

They are prepared using active ingredients under the direction of a prescribing clinician

Days of supply: 90, Dispense quantity: 90 tablets

Yeo and colleagues explained that with rising obesity in the U.S., the increasing prevalence of GLP-1 receptor agonists prescribed for obesity may contribute to drug shortages. Further, drug shortages may exacerbate the existing nationwide racial and ethnic disparities in GLP-1 receptor agonist prescriptions, they wrote, adding that the results suggest a call for strategies to address the growing demand and ensure equitable access to the drugs.

But its a game of whack-a-mole: New sites pop up all the time, and neither the NABP nor the FDA has reviewed them all

Sun and Roy, 2021)